Global Information
회사소개 | 문의 | 비교리스트

세계의 알레르기성 결막질환 치료제 시장(2019-2023년)

Global Eye Allergy Therapeutics Market 2019-2023

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2019년 05월 상품 코드 851226
페이지 정보 영문 140 Pages
가격
US $ 2,500 ₩ 2,971,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,565,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,753,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,942,000 PDF (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 알레르기성 결막질환 치료제 시장(2019-2023년) Global Eye Allergy Therapeutics Market 2019-2023
발행일 : 2019년 05월 페이지 정보 : 영문 140 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 알레르기성 결막질환 치료제(Eye Allergy Therapeutics) 시장은 1일 1회 투여형 제품에 대한 미충족 요구가 높습니다. 현재 알레르기성 결막질환에 사용되는 약은 눈의 가려움 및 충혈을 억제하나 부작용의 발현 가능성이 있어 이 치료제의 장기 사용은 제한되고 있습니다. 그 결과, 효과가 높고 부작용이 없는 즉효성 치료제의 개발이 요구되고 있으며, 이는 결과적으로 이 시장의 성장을 촉진할 것으로 예측됩니다. 이 시장은 2023년까지 약 5%의 CAGR로 추이할 것으로 예측됩니다.

세계의 알레르기성 결막질환 치료제 시장을 조사했으며, 시장 개요, 제품·지역별 시장 규모의 추이와 예측, 시장 성장요인 및 과제 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

제1장 개요

제2장 리포트 범위

제3장 시장 상황

  • 시장 에코시스템
  • 시장 특성
  • 시장 세분화 분석

제4장 시장 규모

  • 시장의 정의
  • 시장 규모
  • 시장 규모 및 예측

제5장 Five Forces 분석

  • 바이어의 교섭력
  • 공급업체의 교섭력
  • 신규 진출의 위협
  • 대체품의 위협
  • 경쟁 상대의 위협
  • 시장 현황

제6장 알레르기성 결막질환 : 개요

제7장 파이프라인 분석

제8장 시장 세분화 : 제품별

  • 시장 세분화 : 제품별
  • 시장 비교 : 제품별
  • 항히스타민제
  • 비만세포 안정제
  • 코르티코스테로이드
  • 면역조절제
  • 기타
  • 시장 기회 : 제품별

제9장 고객 상황

제10장 지역 상황

  • 시장 세분화 : 지역별
  • 시장 비교 : 지역별
  • 북미
  • 유럽
  • 아시아
  • 기타 지역
  • 주요 선도 국가
  • 시장 기회

제11장 의사결정 프레임워크

제12장 성장요인과 과제

  • 시장 성장요인
  • 시장이 해결해야 할 과제

제13장 시장 동향

제14장 벤더 구도

  • 개요
  • 창조적 파괴 상황
  • 경쟁 시나리오

제15장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • Akorn Inc.
  • Allergan Plc
  • Bausch Health Companies Inc.
  • Novartis AG
  • Santen Pharmaceutical Co. Ltd.

제16장 부록

  • 조사 방법
  • 약어 리스트
  • 벤더의 시장 포지셔닝 정의

제17장 TECHNAVIO 소개

KSA 19.05.29

About this market

The global eye allergy therapeutics market is currently witnessing a high unmet medical need for a once-daily double-action eye preparation for the treatment of various types of eye allergies. At present, the drugs administered for eye allergies are intended to treat symptoms such as redness and itching, and they provide substantial assistance to patients leaving approximately 20-30% of the patients untreated. Also, the side effects associated with the available therapeutic options limit their use for a long duration. Therefore, the market is currently exhibiting a need for effective multiple-dose therapies that can treat the signs and symptoms of eye allergies with a quick onset of action and without side effects. This is expected to propel the growth of the market during the forecast period. Technavio's analysts have predicted that the eye allergy therapeutics market will register a CAGR of almost 5% by 2023.

Market Overview

Significant comorbidity associated with eye allergies

All types of eye allergies are associated with chronic symptoms such as ocular itching inflammation redness and watery eyes, which are persistently disturbing, having an adverse effect on patients' life. This leads to loss of work performance decreased productivity and increased healthcare costs, which can put a significant economic burden on patients. To avoid the substantial comorbidity associated with eye allergies, people spend on the required therapeutics, which will drive the growth of the market during the forecast period.

Lack of awareness

The level of awareness about eye allergies is generally low. Media and the Internet were the primary sources of information for most people. The level of knowledge and awareness regarding eye allergies are low among medical students and was far lower among those with a non-medical background. The lack of awareness of the symptoms associated with eye allergies and the negligence in seeking medical help for their treatment are expected to limit the growth of the market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the eye allergy therapeutics market during 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented. The presence of several companies, including Akorn Inc. and Allergan Plc, the competitive environment is quite intense. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies. Bausch Health Companies Inc., Novartis AG, and Santen Pharmaceutical Co. Ltd. are some of the major companies covered in this report.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: EYE ALLERGY: AN OVERVIEW

PART 07: PIPELINE ANALYSIS

PART 08: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Antihistamines - Market size and forecast 2018-2023
  • Mast cell stabilizers - Market size and forecast 2018-2023
  • Corticosteroids - Market size and forecast 2018-2023
  • Immunomodulators - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Akorn Inc.
  • Allergan Plc
  • Bausch Health Companies Inc.
  • Novartis AG
  • Santen Pharmaceutical Co. Ltd.

PART 16: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 17: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global pharmaceuticals market
  • Exhibit 02: Segments of global pharmaceuticals market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Facts about eye allergy
  • Exhibit 18: Pathophysiology of eye allergy
  • Exhibit 19: Pipeline landscape
  • Exhibit 20: Some key clinical trials: Eye allergy therapeutics
  • Exhibit 21: Product - Market share 2018-2023 (%)
  • Exhibit 22: Comparison by product
  • Exhibit 23: Antihistamines - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Classification of antihistamines.
  • Exhibit 25: Example of antihistamine ophthalmic drops
  • Exhibit 26: Antihistamines - Year-over-year growth 2019-2023 (%)
  • Exhibit 27: Mast cell stabilizers - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 28: Examples of mast cell stabilizer ophthalmic drops
  • Exhibit 29: Mast cell stabilizers - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Corticosteroids - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Examples of corticosteroid ophthalmic drops
  • Exhibit 32: Side effects of corticosteroid ophthalmic drops
  • Exhibit 33: Corticosteroids - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: Immunomodulators - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: Examples of immunosuppressant ophthalmic drops
  • Exhibit 36: Immunomodulators - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 38: Examples of decongestant ophthalmic drops
  • Exhibit 39: Example of NSAID ophthalmic drops
  • Exhibit 40: Examples of artificial tears
  • Exhibit 41: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 42: Market opportunity by product
  • Exhibit 43: Customer landscape
  • Exhibit 44: Market share by geography 2018-2023 (%)
  • Exhibit 45: Geographic comparison
  • Exhibit 46: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 47: ALLEVIATE trial in allergic conjunctivitis patients
  • Exhibit 48: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 49: Top 3 countries in North America
  • Exhibit 50: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 51: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 52: Top 3 countries in Europe
  • Exhibit 53: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 54: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 55: Top 3 countries in Asia
  • Exhibit 56: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 57: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 58: Top 3 countries in ROW
  • Exhibit 59: Key leading countries
  • Exhibit 60: Market opportunity
  • Exhibit 61: Impact of allergy symptoms on professional and personal lives of patients
  • Exhibit 62: Pharmacologic treatment for allergic conjunctivitis
  • Exhibit 63: Impact of drivers and challenges
  • Exhibit 64: Benefits associated with SCIT
  • Exhibit 65: Risk factors that increase susceptibility to eye allergies
  • Exhibit 66: Vendor landscape
  • Exhibit 67: Landscape disruption
  • Exhibit 68: Vendors covered
  • Exhibit 69: Vendor classification
  • Exhibit 70: Market positioning of vendors
  • Exhibit 71: Akorn Inc. - Vendor overview
  • Exhibit 72: Akorn Inc. - Business segments
  • Exhibit 73: Akorn Inc. - Organizational developments
  • Exhibit 74: Akorn Inc. - Segment focus
  • Exhibit 75: Akorn Inc. - Key offerings
  • Exhibit 76: Akorn Inc. - Key customers
  • Exhibit 77: Allergan Plc - Vendor overview
  • Exhibit 78: Allergan Plc - Business segments
  • Exhibit 79: Allergan Plc - Organizational developments
  • Exhibit 80: Allergan Plc - Geographic focus
  • Exhibit 81: Allergan Plc - Segment focus
  • Exhibit 82: Allergan Plc - Key offerings
  • Exhibit 83: Allergan Plc - Key customers
  • Exhibit 84: Bausch Health Companies Inc. - Vendor overview
  • Exhibit 85: Bausch Health Companies Inc. - Business segments
  • Exhibit 86: Bausch Health Companies Inc. - Organizational developments
  • Exhibit 87: Bausch Health Companies Inc. - Geographic focus
  • Exhibit 88: Bausch Health Companies Inc. - Segment focus
  • Exhibit 89: Bausch Health Companies Inc. - Key offerings
  • Exhibit 90: Bausch Health Companies Inc. - Key customers
  • Exhibit 91: Novartis AG - Vendor overview
  • Exhibit 92: Novartis AG - Business segments
  • Exhibit 93: Novartis AG - Organizational developments
  • Exhibit 94: Novartis AG - Geographic focus
  • Exhibit 95: Novartis AG - Segment focus
  • Exhibit 96: Novartis AG - Key offerings
  • Exhibit 97: Novartis AG - Key customers
  • Exhibit 98: Santen Pharmaceutical Co. Ltd. - Vendor overview
  • Exhibit 99: Santen Pharmaceutical Co. Ltd. - Business segments
  • Exhibit 100: Santen Pharmaceutical Co. Ltd. - Organizational developments
  • Exhibit 101: Santen Pharmaceutical Co. Ltd. - Geographic focus
  • Exhibit 102: Santen Pharmaceutical Co. Ltd. - Segment focus
  • Exhibit 103: Santen Pharmaceutical Co. Ltd. - Key offerings
  • Exhibit 104: Santen Pharmaceutical Co. Ltd. - Key customers
  • Exhibit 105: Validation techniques employed for market sizing
  • Exhibit 106: Definition of market positioning of vendors
Back to Top
전화 문의
F A Q